Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone for prevention of intestinal radiation-induced fibrosis in rectal cancer
ChiCTR2100044973Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Intestinal fibrosis and rectal cancer comparing Pirfenidone with Placebo (2 arms). Primary endpoint: Degree of fibrosis at the proximal rectum (10 cm from tumor). Started May 2021; status: recruiting.
02
Drugs
pirfenidone
03
Conditions
Intestinal fibrosisrectal cancer
Beyond the preview
Go deeper on ChiCTR2100044973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044973.